KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short-Term Debt issuances (2017 - 2018)

Neogenomics' Short-Term Debt issuances history spans 7 years, with the latest figure at $5.0 million for Q4 2018.

  • For Q4 2018, Short-Term Debt issuances changed N/A year-over-year to $5.0 million; the TTM value through Dec 2019 reached $5.0 million, down 66.67%, while the annual FY2018 figure was $15.0 million, 500.96% up from the prior year.
  • Short-Term Debt issuances reached $5.0 million in Q4 2018 per NEO's latest filing, down from $10.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $10.0 million in Q2 2018 to a low of -$2.9 million in Q2 2014.
  • Average Short-Term Debt issuances over 3 years is $1.7 million, with a median of $287000.0 recorded in 2014.
  • Peak YoY movement for Short-Term Debt issuances: plummeted 334.5% in 2014, then surged 111211.11% in 2018.
  • A 3-year view of Short-Term Debt issuances shows it stood at -$2.0 million in 2014, then dropped by 25.68% to -$2.5 million in 2017, then surged by 299.92% to $5.0 million in 2018.
  • Per Business Quant, the three most recent readings for NEO's Short-Term Debt issuances are $5.0 million (Q4 2018), $10.0 million (Q2 2018), and -$2.5 million (Q3 2017).